Oxford Nanopore Technologies plc (LON:ONT) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Broker consensus is “Moderate Buy”: Five of six analysts rate Oxford Nanopore Technologies as a buy, while one recommends holding. The average 12-month price target is GBX 198.60.
• Recent targets range from GBX 153 to GBX 225: JPMorgan raised its target to GBX 220, while RBC maintained an outperform rating with a GBX 225 target; Peel Hunt remains cautious with a GBX 153 target.
• Financial performance remains challenging: The company reported quarterly EPS of negative GBX 4.90, alongside a negative 35.45% return on equity and a negative 54.66% net margin. Shares opened at GBX 173.40, near the upper end of their 12-month range.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is GBX 198.60.

Several research analysts have recently commented on the stock. Citigroup lowered shares of Oxford Nanopore Technologies to a "buy" rating in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a GBX 195 target price on shares of Oxford Nanopore Technologies in a research note on Thursday, August 20th. Royal Bank Of Canada reiterated an "outperform" rating and set a GBX 225 target price on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. JPMorgan Chase & Co. raised their price target on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a research report on Thursday, August 27th. Finally, Peel Hunt restated a "hold" rating and issued a GBX 153 price target on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th.

Insider Buying and Selling

In related news, insider Nick Keher purchased 15,325 shares of the business's stock in a transaction on Friday, September 4th. The shares were bought at an average price of GBX 162 per share, for a total transaction of £24,826.50. Over the last ninety days, insiders acquired 15,993 shares of company stock worth $2,572,680. Insiders own 2.54% of the company's stock.

Oxford Nanopore Technologies Stock Performance

Shares of Oxford Nanopore Technologies stock opened at GBX 173.40 on Monday. The business has a 50-day moving average of GBX 138.71 and a 200 day moving average of GBX 126.86. Oxford Nanopore Technologies has a 12 month low of GBX 95.61 and a 12 month high of GBX 191.40. The stock has a market capitalization of £1.69 billion, a price-to-earnings ratio of -13.87 and a beta of 0.96. The company has a debt-to-equity ratio of 9.86, a current ratio of 3.52 and a quick ratio of 6.01.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last issued its quarterly earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.